CCHR Warns: Millions of Children Exposed to Risky Psychiatric Drugs

LOS ANGELES, Calif., June 2, 2025 (SEND2PRESS NEWSWIRE) — A federal assessment of children's health has identified the widespread prescribing of psychotropic drugs to U.S. youth as a 'public crisis' driven by industry profit motives, flawed science, and systemic conflicts of interest. The U.S. Department of Health and Human Services (HHS) found that stimulants, antidepressants, antipsychotics, and anti-anxiety drugs were leading the surge.[1] According to the Citizens Commission on Human Rights International (CCHR) , a mental health industry watchdog, this is fueling a psychotropic drug market that reaps $22.6 billion annually.
CCHR advised parents to become better informed about the risks of psychotropic drugs, including benzodiazepines or anti-anxiety drugs prescribed to children. CCHR offers a 16-page educational booklet, Psychiatric Drugs & Your Child's Future , and the documentary Dead Wrong , which features bereaved parents who lost children to psychiatric drug effects, especially antidepressants—black box-warned for suicide in 2004, more than 15 years after Food and Drug Administration (FDA) approval.
HHS reported that prescriptions for stimulants rose 250% between 2006 and 2016. By 2022, 11% of all children—and nearly 25% of boys—had a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD), despite no medical test to confirm the behavioral symptoms. Long-term trials of ADHD drugs show no academic, behavioral, or social benefit beyond 14 months—and a loss of height averaging one inch. Teen use of antidepressants increased 1,400% between 1987 and 2014, and over 2 million prescriptions were written for adolescents in 2022 alone.[2]
Antipsychotic drug use among children grew 800% between 1995 and 2009, with 66% prescribed off-label—including for ADHD and 'aggression.' Antipsychotics in adolescent boys may cause up to 5x more gynecomastia (male breast growth); 4x more extrapyramidal effects (movement disorders); and 6–8x more weight gain than placebo. Meanwhile, serious side effects—including seizures, cardiac issues, male breast growth, and prolonged withdrawal syndromes—are widely documented.[3]
CCHR, which has tracked what it calls mass-prescribed drug child abuse since its founding in 1969, said the situation is even more dire than the HHS report reveals. Using data from IQVia's Total Patient Tracker Database for 2020, CCHR found: 1 million 0–17-year-olds were prescribed ADHD stimulants,
15 million were on antidepressants,
15 million were taking anti-anxiety drugs, including highly addictive benzodiazepines, and
829,372 were prescribed antipsychotics known to cause neurological damage.[4]
Combined, over 6.1 million children and teens were drugged—representing more than 8.2% of the U.S. youth population.[5]
Psychotropic polypharmacy is especially prevalent among youth covered by Medicaid. A 2024 study found a rise in multiple drug use in this group, increasing the risk of adverse medical outcomes. Researchers reviewed 126,972 Medicaid recipients who had received at least one psychotropic drug and had continuous coverage for 90+ days. The prevalence of polypharmacy rose from 4.2% in 2015 to 4.6% in 2020, with higher rates among those in foster care (10.8% to 11.3%), the Children's Health Program (2.2% to 2.8%), and low-income households (2.1% to 2.8%).[6]
The problem is exacerbated by drug misuse. In 2018, almost 16% of U.S. college students said they misused prescription stimulants.[7] A 2023 survey of college students who reported using prescription stimulants revealed that about 21.7% had taken a higher-than-prescribed dose in the past three months.[8] Many students mistakenly believe one ADHD stimulant to be no more harmful than coffee, assuming it is safe because it's prescribed by doctors.[9]
Youth drug overdoses on prescription drugs is also a serious risk. In 2019, 4,777 U.S. youth died from drug overdoses; 727 involved benzodiazepines and 902 involved psychostimulants. In 2020, 2,928 nonfatal benzodiazepine overdoses were reported among youth aged 15 to 24. Among these, 29% had a prescription in the previous month and 42% within six months. Intentional overdoses were more likely among those with recent prescriptions. Fifty-six percent of benzodiazepine overdoses were intentional compared with 40% of stimulant overdoses.[10]
The FDA issued a black box warning in 2020 for benzodiazepines, citing 'risks of abuse, misuse, and addiction, which can lead to overdose or death.'[11]
A 2022 study in Pediatrics found that a quarter of insured teens who overdosed on anxiety or ADHD drugs had received a recent prescription.[12]
HHS linked the rise in drug use to broadened diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), expanded in 2013 by panels with financial ties to the pharmaceutical industry. This contributed to a 40-fold increase in childhood diagnoses such as ADHD and bipolar disorder. Yet, no psychiatric-defined disorder meets the scientific definition of a disease. Former U.S. National Institute of Mental Health Director Thomas Insel stated: 'Unlike our definitions of ischemic heart disease, lymphoma, or AIDS, the DSM diagnoses are based on a consensus about clusters of clinical symptoms, not any objective laboratory measure.'[13]
CCHR, established in 1969 by the Church of Scientology and professor of psychiatry, Dr. Thomas Szasz, has achieved significant reforms in this area, including a 2004 federal law prohibiting schools from forcing students onto psychotropic drugs as a requisite for their education. Jan Eastgate, President of CCHR International, said: 'Profit-driven psychiatry is putting children at risk with no science to justify diagnoses or drugs.' CCHR stresses that the nation's child mental health system requires a complete overhaul—eliminating treatments that expose children to suicide, addiction, physical harm, and institutional profiteering.
To learn more, visit: https://www.cchrint.org/2025/05/30/federal-report-confirms-psychotropic-drugging-children-national-crisis/
Sources:
[1] 'Making Our Children Healthy Again,' Make America Healthy Again Commission (MAHA), 22 May 2025, p. 54
[2] MAHA Report, pp. 16-17
[3] MAHA Report, pp. 54-56
[4] https://www.cchrint.org/psychiatric-drugs/children-on-psychiatric-drugs/
[5] https://www.childstats.gov/AMERICASCHILDREN/tables/pop1.asp
[6] 'Psychotropic Polypharmacy Trends Rise Among Child, Adolescent Medicaid Beneficiaries,' Psychiatric Times, 21 May 2024
[7] https://news.osu.edu/misuse-of-stimulants-remains-a-top-concern-on-college-campuses/
[8] https://www.statista.com/statistics/1125729/us-college-student-prescription-stimulant-overuse/
[9] 'Are You Surprised By the 4 Most Abused Study Drugs?' Detox.com, 28 Feb. 2018
[10] https://www.clinicaladvisor.com/news/teens-overdosing-prescribed-anxiety-adhd-medications/ ; https://pmc.ncbi.nlm.nih.gov/articles/PMC9097826/
[11] https://www.cchrint.org/2023/08/30/mental-health-watchdog-highlights-global-benzodiazepine-risks/ ; 'FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. Includes potential for abuse, addiction, and other serious risks,' FDA, 23 Sept. 2020
[12] https://doi.org/10.1542/peds.2021-055226
[13] 'The NIMH Withdraws Support for DSM-5,' Psychology Today, 4 May 2003
MULTIMEDIA:
Image link for media: https://www.Send2Press.com/300dpi/25-0602-s2p-cchrcrisis-300dpi.jpg
Image caption: 'Profit-driven psychiatry is putting children at risk with no science to justify diagnoses or drugs.' – Jan Eastgate, President of CCHR International.
NEWS SOURCE: Citizens Commission on Human Rights
Keywords: Religion and Churches, Citizens Commission on Human Rights, CCHR International, CCHR International, Jan Eastgate, psychotropic drug market, LOS ANGELES, Calif.
This press release was issued on behalf of the news source (Citizens Commission on Human Rights) who is solely responsibile for its accuracy, by Send2Press® Newswire . Information is believed accurate but not guaranteed. Story ID: S2P126647 APNF0325A
To view the original version, visit: https://www.send2press.com/wire/cchr-warns-millions-of-children-exposed-to-risky-psychiatric-drugs/
© 2025 Send2Press® Newswire, a press release distribution service, Calif., USA.
RIGHTS GRANTED FOR REPRODUCTION IN WHOLE OR IN PART BY ANY LEGITIMATE MEDIA OUTLET - SUCH AS NEWSPAPER, BROADCAST OR TRADE PERIODICAL. MAY NOT BE USED ON ANY NON-MEDIA WEBSITE PROMOTING PR OR MARKETING SERVICES OR CONTENT DEVELOPMENT.
Disclaimer: This press release content was not created by nor issued by the Associated Press (AP). Content below is unrelated to this news story.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

32 minutes ago

• Yahoo

What the business world has to like (and not) in the Senate version of Trump's 'big, beautiful bill'

The business community has some clear wins in a Senate version of President Trump's "big, beautiful bill" but it isn't getting everything it wants. The Senate's Finance Committee's 549-page blueprint contains significant changes, especially on taxes, Medicaid funding, and clean energy. One proposal was quickly embraced by the business community: a Senate-side push to make corporate tax deductions permanent around things like interest payments and new capital investments. But a less popular idea is the survival of the so-called revenge tax that would allow the government to levy new duties on foreign nations and their businesses. That idea was introduced in the House version and sparked fears of reduced foreign investment. The version released last Monday pares back the tax but doesn't eliminate it entirely, as corporate lobbyists had asked. Specific industries also have plenty at stake from Senate changes if they make it into law. Businesses that work in clean energy will have more time to adjust to the phase-out of Biden-era credits. Restaurants and gig economy companies have more limited tax breaks for tips and overtime. Healthcare providers will also have to adjust to even steeper cuts to Medicaid's provider tax structure — perhaps the most surprising and significant overall change in the Senate version. What the Senate version of the bill doesn't appear to have — as Elon Musk and others had pushed for — is a significant change in the final price tag. Both versions are expected to add trillions of dollars to the debt. The Senate version also raises the debt ceiling by $5 trillion, compared with $4 trillion in the House version. The bill does have one clear cost-saving measure: slashing the annual deduction for individual state and local taxes (SALT) from $40,000 to $10,000. But that provision is described even in the bill's official summary as "the subject of continuing negotiations," with defenders of the deduction pledging to restore the full credit forthwith. The Senate version earned a quick flurry of Republican pledges — from fiscal hawks to defenders of those SALT deductions to those who object to the Medicaid cuts — to vote no if the final version isn't changed to their liking. "We're not seriously addressing our long-term deficit and debt," Sen. Ron Johnson of Wisconsin told reporters soon after the unveiling, reiterating that he remains a no. The back and forth comes just weeks ahead of Republicans' self-imposed deadline to get the bill to the president's desk by July 4. Senate Majority Leader John Thune has said sticking to that timeline means Senate passage by the end of this coming week. Ed Mills of Raymond James offered in a note that "we continue to view the July 4 target as ambitious" — suggesting that SALT and Medicaid provisions in particular could be under continued debate in the days ahead. Here is a closer look at some of the major business world changes being proposed by the Senate: A key focus for business owners is a series of tax deductions that will reinstate credits for corporations around things like property depreciation, capital investments, new factory construction, interest expenses, and research and development costs. These provisions were present in the House version but only temporarily. Permanency was a key Senate priority once they took over, even as it is expected to increase the price tag. The bill "powers the economy by permanently extending critical pro-growth provisions and introduces new incentives for domestic investment, providing certainty for American job creators to spur domestic economic activity and invest in their workers," offered Senate Finance Committee Chairman Mike Crapo as he unveiled these provisions. The Senate version also enhances credits for "opportunity zones," which provide tax relief in rural and distressed communities. The bill also includes Trump's campaign promises of no taxes on tips and overtime, but in a more limited form. Employees would be able to deduct up to $25,000 annually for tips and overtime, in contrast to the House's approach of 100% deductibility under certain income limits. The Senate blueprint also includes a rollback of clean energy credits for things like solar panels and electric vehicles. The changes in the Senate would make that phaseout slower — zeroing out some key credits by 2028 — but with a bottom line that Republicans across the spectrum are united in eliminating these benefits entirely. Amy Hanauer, executive director of the left-leaning Institute on Taxation and Economic Policy, reacted to the released proposal by saying that "the emerging clean energy economy will be curtailed and for what?" "Our communities will be worse off as a result of this legislation,' she added. On the fossil fuel side, the Senate bill continues to include changes to make permitting less laborious, open up new lease sales, and reverse a fee on excess methane emissions. The Senate bill also includes a controversial plan to limit the ability of states to regulate artificial intelligence. The Senate's provisions are less airtight, stopping short of the outright ban proposed by the House, but are expected to remain a point of contention and potentially an issue for the Senate parliamentarian, given the Senate's complex reconciliation rules. Other changes in the bill appear to cut against business interests at least slightly. The Senate bill makes permanent the so-called pass-through deduction — formally called a 199A deduction for small businesses — but at the current rate of 20%. The House version also had permanency, but at a higher rate of 23%. Meanwhile, a clear focus of business lobbyist ire has remained in the bill, but in a slightly diminished form: the so-called revenge tax. This idea would allow a president to punish companies and countries if they adhere to foreign laws that policymakers find objectionable. In Trump's case, things like the digital services taxes that often hit tech companies overseas. The Senate version, in a nod to the flurry of concerns, set a maximum rate of 15% and delayed implementation until 2027 but kept the concept intact. In addition to that tax, the SALT and Medicaid changes are likely to be most in focus in the days and weeks ahead. Tobin Marcus of Wolfe Research noted Tuesday morning that "SALT changes underscore the reality that this is another step forward in negotiations, not the final answer." He added that "we still view late July as the real deadline." This story has been updated. Ben Werschkul is a Washington correspondent for Yahoo Finance. Click here for political news related to business and money policies that will shape tomorrow's stock prices Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Miami Herald

40 minutes ago

• Miami Herald

Donald Trump's SNAP Benefit Cut Plans Suffer Blow

A plan by Republicans to shift a portion of federal food stamp costs to state governments suffered a major setback after the Senate parliamentarian found it would violate chamber rules. The blocked provision was an attempt to reduce federal spending on the Supplemental Nutrition Assistance Program (SNAP), affecting more than 40 million low-income Americans who rely on food aid. The shift would have transferred major SNAP costs to the states, requiring them to pay at least 5 percent—and potentially more—of benefit costs, which analysts warned could result in significant cuts to nutrition support. The parliamentarian's decision places additional pressure on the bill's champions to find alternative means to fund tax cuts without imperiling food assistance, Medicaid, or other federal support programs. The provision, a cornerstone of Republican efforts to offset the costs of President Donald Trump's multitrillion-dollar tax and spending legislation, has been ruled inadmissible under Senate rules, sending GOP leaders scrambling to revise the mega bill. The ruling, issued by Senate parliamentarian Elizabeth MacDonough, came as the package prepared for a vote. While her opinions are advisory, they are rarely ignored in lawmaking practice. Republican lawmakers are now searching for new savings as they continue to advance Trump's legislative priorities despite the setback. MacDonough declared the SNAP cost-sharing plan noncompliant with the chamber's budget reconciliation rules, specifically the Byrd Rule, which bars certain policy measures from being attached to budget bills. The proposal would have shifted billions of dollars in SNAP costs from the federal government to the states, creating a new fiscal obligation for state governments and threatening coverage for millions. House Passes Bill with GOP SNAP Cuts The House passed the broader tax and spending package along party lines in May 2025, including a provision to require states to fund at least 5 percent of SNAP benefits and more for high error rates. The House-passed measure's SNAP provision was projected to save about $128 billion. Republican leaders had hoped these savings would help offset the bill's $4.5 trillion in tax cuts and new spending. Other Key Provisions Beyond SNAP, the package includes an extension and expansion of individual and business tax cuts, new work requirements for Medicaid recipients, cuts to federal health and nutrition programs, increased military and border security funding, and the elimination of taxes on tips for service workers. GOP Paths Forward Republican leaders, including Senate Agriculture Committee Chair John Boozman of Arkansas, said they were exploring options to keep the legislation on track while still delivering savings elsewhere. Options range from modifying the disputed SNAP provision to removing it entirely or risking a procedural vote requiring 60 votes—an unlikely scenario in the current Senate. Impact on SNAP Recipients The plan would have expanded work requirements to older adults (up to age 65), a component that remains in the bill for now. Democrats and anti-hunger advocates warned of significant harm to those in need, with more than 3 million individuals projected to lose food stamp access based on Congressional Budget Office estimates. Additional Rulings Expected The Senate parliamentarian is also expected to rule on other elements in the bill, including limits on immigrant eligibility for nutrition aid and changes to federal agencies, with further decisions likely to shape the final legislation. Minnesota Senator Amy Klobuchar, the top Democrat on the Senate Agriculture, Nutrition and Forestry Committee, said: "We will keep fighting to protect families in need," opposing shifts in SNAP costs to states, which she said would result in significant benefit cuts. Arkansas Senator John Boozman, chair of the Senate Agriculture Committee, said Republicans are "exploring options" to comply with Senate rules, while supporting those reliant on SNAP. Senate Republicans are expected to revise the bill to comply with the parliamentarian's rulings or drop the contested SNAP provisions. Further decisions from the adviser on other elements of the megabill are anticipated before any final Senate vote. This article contains reporting from The Associated Press. Related Articles When Are July 2025 SNAP Payments Coming?Republicans Out Of Step With Voters On Medicaid FundingNew York State Facing Lawsuit Over SNAP BenefitsSNAP Recipients Get Extra Money This Month in California 2025 NEWSWEEK DIGITAL LLC.

Bloomberg

2 hours ago

• Bloomberg

The Issue That Can Damage Republicans the Most

Amid all the news that Donald Trump creates, and there's a lot, one story stands out for its unrivaled potential to damage the president's political standing: the Republican effort to pass a huge budget bill that, among other things, would kick millions of people off Medicaid. Above all else, this is what Democrats should be focused on. The polling on this legislation is terrible, and with good reason. It's one thing to ask for belt-tightening in a spirit of shared sacrifice, but the One Big Beautiful Bill Act doesn't reduce the deficit at all — on the contrary, it adds nearly $3 trillion to the national debt. And that's an underestimate. According to the Committee for a Responsible Federal Budget, if all its changes were made permanent, the bill would add closer to $5 trillion in new debt. Nor can economic growth avert this fiscal catastrophe. The Congressional Budget Office estimates that on a 'dynamic scoring' basis — which usually reduces the cost of legislation — the price tag of the bill actually goes up by nearly $400 billion due to higher interest rates. This upward pressure on interest rates will spread through the economy and slow growth.